Ligand validation:6IPB

TLA: L(+)-TARTARIC ACID

TLA is a Ligand Of Interest in 6IPB designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6IPB_TLA_A_501	99%	30%	0.056	0.988	1.57	1.25	2	2	0	0	100%	1
6IPB_TLA_C_501	98%	41%	0.062	0.985	1.42	0.89	1	1	1	0	100%	1
6IPB_TLA_B_501	98%	25%	0.061	0.983	1.73	1.36	2	2	0	0	100%	1
6IPB_TLA_D_501	96%	20%	0.063	0.973	1.5	1.84	1	4	0	0	100%	1
7YAN_TLA_B_501	76%	38%	0.1	0.935	1.21	1.23	1	1	2	0	100%	1
7CJX_TLA_A_501	55%	47%	0.107	0.875	1	1.06	-	1	0	0	100%	1
2BLR_TLA_A_1207	100%	32%	0.023	0.994	1.77	0.94	2	-	0	0	100%	1
3WOU_TLA_A_302	100%	45%	0.029	0.996	1.18	0.96	-	-	0	0	100%	1
2VI4_TLA_A_1207	100%	41%	0.029	0.994	1.41	0.88	1	-	0	0	100%	1
3AL7_TLA_A_220	100%	43%	0.033	0.997	1.44	0.78	1	-	0	0	100%	1
5YYP_TLA_A_301	100%	26%	0.032	0.996	1.6	1.38	2	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.